LAURIE VELTRI: Open Payments
NPI 1669976569 · FARMINGTON HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 143 payments from 29 companies in 2025. Trend: 2023 $6,813 · 2024 $5,175 · 2025 $2,638
Food & beverage: $2,527Education: $111
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 30 | $386 |
| Novartis Pharmaceuticals Corporation | 22 | $271 |
| JAZZ PHARMACEUTICALS INC. | 13 | $266 |
| ARGENX US, INC. | 10 | $204 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $170 |
| ABBVIE INC. | 7 | $141 |
| Neurocrine BioSciences, Inc. | 6 | $132 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $120 |
| SK Life Science, Inc. | 3 | $91 |
| HARMONY BIOSCIENCES LLC | 3 | $90 |
Products named: KESIMPTA, VYVGART HYTRULO, XYWAV, HYQVIA, Rystiggo, Nayzilam, INGREZZA, FYCOMPA.
Industry payments across MI — which companies pay providers there.
